Impact BioMedical Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IBO NYSE American 2836 www.impactbiomedinc.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Impact BioMedical Inc.

Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - Aug 18th, 2025 6:30 am
Top Midday Gainers - Jun 23rd, 2025 12:12 pm
Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger - Jun 23rd, 2025 5:52 am
Impact Biomedical Inc. Announcement Stock Activity/Pricing - Mar 21st, 2025 12:38 pm
Why Impact Biomedical Inc. (IBO) Surged On Thursday? - Mar 21st, 2025 4:34 am
DSS, Inc. Announces Sale of Celios® to Impact BioMedical, Streamlining Portfolio for Strategic Growth - Feb 26th, 2025 6:30 am
Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room Air Quality” - Feb 26th, 2025 6:30 am
Impact BioMedical Inc. to Present at The Microcap Conference - Jan 23rd, 2025 2:30 pm